Table 1.
| Cell Line | Cell-surface Vimentin |
Cell Line | Cell-surface Vimentin |
|---|---|---|---|
| Breast | Colon | ||
| MCF-7 (H) | + | DLD-1 (H) | ++ |
| SKBR3 (H) | + | GEO (H) | ++ |
| MDA-MB-231 (H) | + | OS-187 (H) | ++ |
| MDA-MB-453 (H) | + | SW620 (H) | + |
| MDA-MB-458 (H) | ++ | SW480 (H) | + |
| 4T1 (M) | + | HCT-116 (H) | + |
| Liver | HT-29 (H) | ++ | |
| AMC14 (M) | ++ | Caco-2 (H) | + |
| CT-26 (M) | + | ||
| Brain | Bladder | ||
| SKNAS (H) | ++ | RT4V6 (H) | + |
| SKNBE2 (H) | +++ | T24 (H) | ++ |
| NGP (H) | + | Pancreas | |
| SH-SY5Y (H) | ++ | PANC-1 (H) | ++ |
| LAN5 (H) | ++ | MiaPACA-2 (H) | + |
| KCN (H) | + | ||
| DBT (M) | + | ||
| U251 (H) | + |
(H): Human, (M): Mouse. Cell-surface vimentin was scored using flow cytometric analysis by measuring mean fluorescence intensity of CSV.
“-”: Not detectable, “+, ++, +++”: <2, <4, >4 fold presence compared to isotype control.